{"id":145792,"date":"2025-10-22T18:19:11","date_gmt":"2025-10-22T11:19:11","guid":{"rendered":"https:\/\/vnras.com\/drug\/?post_type=product&p=145792"},"modified":"2025-10-22T18:21:16","modified_gmt":"2025-10-22T11:21:16","slug":"galeptic-300","status":"publish","type":"product","link":"https:\/\/vnras.com\/drug\/galeptic-300\/","title":{"rendered":"Galeptic 300"},"content":{"rendered":"

Trong b\u00e0i vi\u1ebft n\u00e0y, d\u01b0\u1ee3c s\u0129 L\u01b0u V\u0103n Ho\u00e0ng<\/a> gi\u1edbi thi\u1ec7u \u0111\u1ebfn c\u00e1c b\u1ea1n thu\u1ed1c Galeptic 300 \u0111\u01b0\u1ee3c s\u1ea3n xu\u1ea5t b\u1edfi C\u00f4ng ty TNHH Ha san – Dermapharm c\u00f3 s\u1ed1 \u0111\u0103ng k\u00fd l\u01b0u h\u00e0nh t\u1ea1i Vi\u1ec7t Nam l\u00e0 VD-21097-14<\/p>\n

Galeptic 300 l\u00e0 thu\u1ed1c g\u00ec?<\/b><\/h2>\n

Th\u00e0nh ph\u1ea7n<\/b><\/h3>\n

Trong m\u1ed7i vi\u00ean u\u1ed1ng Galeptic 300<\/strong> c\u00f3 ch\u1ee9a:<\/p>\n

    \n
  • Gabapentin 300 mg<\/li>\n
  • T\u00e1 d\u01b0\u1ee3c: Lactose monohydrat, talc, tinh b\u1ed9t ng\u00f4, v\u1ecf nang c\u1ee9ng s\u1ed1 1<\/li>\n<\/ul>\n

    D\u1ea1ng b\u00e0o ch\u1ebf: Vi\u00ean nang c\u1ee9ng<\/p>\n

    Tr\u00ecnh b\u00e0y<\/b><\/h3>\n

    S\u0110K: VD-21097-14<\/p>\n

    Quy c\u00e1ch \u0111\u00f3ng g\u00f3i: H\u1ed9p 3 v\u1ec9 x 10 vi\u00ean<\/p>\n

    Xu\u1ea5t x\u1ee9: Vi\u1ec7t Nam<\/p>\n

    H\u1ea1n s\u1eed d\u1ee5ng: 36 th\u00e1ng<\/p>\n

    T\u00e1c d\u1ee5ng c\u1ee7a thu\u1ed1c Galeptic 300<\/b><\/h2>\n

    C\u01a1 ch\u1ebf t\u00e1c d\u1ee5ng<\/b><\/h3>\n

    Gabapentin c\u00f3 h\u00ecnh th\u00e1i c\u1ea5u tr\u00fac t\u01b0\u01a1ng t\u1ef1 axit gamma-aminobutyric (GABA), m\u1ed9t ch\u1ea5t truy\u1ec1n tin th\u1ea7n kinh c\u00f3 t\u00e1c d\u1ee5ng \u1ee9c ch\u1ebf trong h\u1ec7 th\u1ea7n kinh trung \u01b0\u01a1ng. Tuy v\u1eady, ho\u1ea1t ch\u1ea5t n\u00e0y kh\u00f4ng t\u01b0\u01a1ng t\u00e1c tr\u1ef1c ti\u1ebfp v\u1edbi c\u00e1c th\u1ee5 th\u1ec3 GABA, c\u0169ng kh\u00f4ng l\u00e0m thay \u0111\u1ed5i qu\u00e1 tr\u00ecnh t\u1ed5ng h\u1ee3p, ph\u00e2n gi\u1ea3i ho\u1eb7c t\u00e1i h\u1ea5p thu GABA trong n\u00e3o b\u1ed9. Cho \u0111\u1ebfn nay, c\u01a1 ch\u1ebf t\u00e1c d\u1ee5ng ch\u00ednh x\u00e1c c\u1ee7a Gabapentin v\u1eabn ch\u01b0a \u0111\u01b0\u1ee3c x\u00e1c \u0111\u1ecbnh \u0111\u1ea7y \u0111\u1ee7.<\/p>\n

    \u0110\u1eb7c \u0111i\u1ec3m d\u01b0\u1ee3c \u0111\u1ed9ng h\u1ecdc<\/b><\/h3>\n

    H\u1ea5p thu: Sau khi u\u1ed1ng, thu\u1ed1c \u0111\u01b0\u1ee3c h\u1ea5p th\u1ee5 t\u1ea1i \u0111\u01b0\u1eddng ti\u00eau h\u00f3a qua m\u1ed9t c\u01a1 ch\u1ebf c\u00f3 gi\u1edbi h\u1ea1n. Khi li\u1ec1u d\u00f9ng t\u0103ng, m\u1ee9c \u0111\u1ed9 h\u1ea5p thu l\u1ea1i gi\u1ea3m, do \u0111\u1eb7c t\u00ednh b\u00e3o h\u00f2a. Th\u1eddi gian \u0111\u1ea1t n\u1ed3ng \u0111\u1ed9 \u0111\u1ec9nh trong huy\u1ebft t\u01b0\u01a1ng th\u01b0\u1eddng v\u00e0o kho\u1ea3ng 2 gi\u1edd sau khi s\u1eed d\u1ee5ng.<\/p>\n

    Ph\u00e2n b\u1ed1: Thu\u1ed1c lan t\u1ecfa \u0111\u1ebfn nhi\u1ec1u c\u01a1 quan v\u00e0 m\u00f4 trong c\u01a1 th\u1ec3, \u0111\u1ed3ng th\u1eddi c\u00f3 kh\u1ea3 n\u0103ng b\u00e0i ti\u1ebft v\u00e0o s\u1eefa m\u1eb9. T\u1ef7 l\u1ec7 g\u1eafn k\u1ebft v\u1edbi protein huy\u1ebft t\u01b0\u01a1ng r\u1ea5t th\u1ea5p, ch\u1ec9 d\u01b0\u1edbi 3%.<\/p>\n

    Chuy\u1ec3n h\u00f3a: Ho\u1ea1t ch\u1ea5t n\u00e0y g\u1ea7n nh\u01b0 kh\u00f4ng b\u1ecb bi\u1ebfn \u0111\u1ed5i trong c\u01a1 th\u1ec3, t\u1ee9c l\u00e0 kh\u00f4ng tr\u1ea3i qua qu\u00e1 tr\u00ecnh chuy\u1ec3n h\u00f3a \u0111\u00e1ng k\u1ec3.<\/p>\n

    Th\u1ea3i tr\u1eeb: Gabapentin ch\u1ee7 y\u1ebfu \u0111\u01b0\u1ee3c b\u00e0i ti\u1ebft qua th\u1eadn d\u01b0\u1edbi d\u1ea1ng kh\u00f4ng \u0111\u1ed5i. \u1ede nh\u1eefng ng\u01b0\u1eddi c\u00f3 th\u1eadn ho\u1ea1t \u0111\u1ed9ng b\u00ecnh th\u01b0\u1eddng, th\u1eddi gian b\u00e1n th\u1ea3i c\u1ee7a thu\u1ed1c dao \u0111\u1ed9ng t\u1eeb 5 \u0111\u1ebfn 7 gi\u1edd. V\u1edbi b\u1ec7nh nh\u00e2n suy gi\u1ea3m ch\u1ee9c n\u0103ng th\u1eadn, vi\u1ec7c \u0111i\u1ec1u ch\u1ec9nh li\u1ec1u d\u00f9ng l\u00e0 b\u1eaft bu\u1ed9c nh\u1eb1m duy tr\u00ec hi\u1ec7u qu\u1ea3 \u0111i\u1ec1u tr\u1ecb v\u00e0 gi\u1ea3m nguy c\u01a1 t\u00e1c d\u1ee5ng ph\u1ee5.<\/p>\n

    Thu\u1ed1c Galeptic 300 \u0111\u01b0\u1ee3c ch\u1ec9 \u0111\u1ecbnh trong b\u1ec7nh g\u00ec?<\/b><\/h2>\n

    \u0110\u1ed9ng kinh c\u1ee5c b\u1ed9<\/p>\n

    \u0110au d\u00e2y th\u1ea7n kinh do nguy\u00ean nh\u00e2n ngo\u1ea1i vi, bao g\u1ed3m c\u1ea3 \u0111au sau b\u1ec7nh zona<\/p>\n

    \"Galeptic
    Thu\u1ed1c Galeptic 300 c\u00f3 t\u00e1c d\u1ee5ng \u0111i\u1ec1u tr\u1ecb b\u1ec7nh l\u00fd th\u1ea7n kinh<\/figcaption><\/figure>\n

    Li\u1ec1u d\u00f9ng v\u00e0 c\u00e1ch s\u1eed d\u1ee5ng<\/b><\/h2>\n

    Li\u1ec1u d\u00f9ng<\/b><\/h3>\n

    Li\u1ec1u d\u00f9ng t\u00ednh cho vi\u00ean nang Galeptic 300<\/strong> nh\u01b0 sau:<\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
    \u0110\u1ed1i t\u01b0\u1ee3ng<\/strong><\/td>\nNg\u00e0y \u0111i\u1ec1u tr\u1ecb<\/strong><\/td>\nLi\u1ec1u d\u00f9ng<\/strong><\/td>\nL\u01b0u \u00fd<\/strong><\/td>\n<\/tr>\n
    Ng\u01b0\u1eddi l\u1edbn & Tr\u1ebb tr\u00ean 12 tu\u1ed5i (\u0110\u1ed9ng kinh)<\/td>\nNg\u00e0y 1<\/td>\n1 vi\u00ean x 1 l\u1ea7n\/ng\u00e0y<\/td>\n<\/td>\n<\/tr>\n
    Ng\u00e0y 2<\/td>\n1 vi\u00ean x 2 l\u1ea7n\/ng\u00e0y<\/td>\n<\/td>\n<\/tr>\n
    Ng\u00e0y 3<\/td>\n1 vi\u00ean x 3 l\u1ea7n\/ng\u00e0y<\/td>\n<\/td>\n<\/tr>\n
    Sau \u0111\u00f3<\/td>\nT\u0103ng 1 vi\u00ean\/ng\u00e0y n\u1ebfu c\u1ea7n, t\u1ed1i \u0111a 8 vi\u00ean\/ng\u00e0y<\/td>\nChia 3\u20134 l\u1ea7n\/ng\u00e0y<\/td>\n<\/tr>\n
    Ng\u01b0\u1eddi suy th\u1eadn<\/td>\n–<\/td>\n\u0110i\u1ec1u ch\u1ec9nh theo \u0111\u1ed9 thanh th\u1ea3i creatinin<\/td>\nChia l\u00e0m 3 l\u1ea7n\/ng\u00e0y<\/td>\n<\/tr>\n
    50\u201370 ml\/ph\u00fat<\/td>\n2\u20134 vi\u00ean\/ng\u00e0y<\/td>\n<\/td>\n<\/tr>\n
    30\u201349 ml\/ph\u00fat<\/td>\n1\u20132 vi\u00ean\/ng\u00e0y<\/td>\n<\/td>\n<\/tr>\n
    15\u201329 ml\/ph\u00fat<\/td>\n1 vi\u00ean\/ng\u00e0y<\/td>\n<\/td>\n<\/tr>\n
    <15 ml\/ph\u00fat<\/td>\n1 vi\u00ean m\u1ed7i 2 ng\u00e0y<\/td>\nN\u1ebfu kh\u00f4ng th\u1ea9m ph\u00e2n m\u00e1u<\/td>\n<\/tr>\n
    Th\u1ea9m ph\u00e2n m\u00e1u<\/td>\nLi\u1ec1u n\u1ea1p: 1\u20131,5 vi\u00ean; duy tr\u00ec: 1 vi\u00ean m\u1ed7i 4 gi\u1edd l\u1ecdc m\u00e1u<\/td>\nTheo ch\u1ec9 \u0111\u1ecbnh b\u00e1c s\u0129<\/td>\n<\/tr>\n
    Tr\u1ebb em 6\u201312 tu\u1ed5i<\/td>\nNg\u00e0y 1<\/td>\n10 mg\/kg\/ng\u00e0y, chia 3 l\u1ea7n<\/td>\n<\/td>\n<\/tr>\n
    Ng\u00e0y 2<\/td>\n20 mg\/kg\/ng\u00e0y, chia 3 l\u1ea7n<\/td>\n<\/td>\n<\/tr>\n
    Ng\u00e0y 3<\/td>\n25\u201335 mg\/kg\/ng\u00e0y, chia 3 l\u1ea7n<\/td>\n<\/td>\n<\/tr>\n
    Duy tr\u00ec<\/td>\n3 vi\u00ean\/ng\u00e0y ho\u1eb7c 4 vi\u00ean\/ng\u00e0y t\u00f9y c\u00e2n n\u1eb7ng<\/td>\nTr\u1ebb 26\u201336 kg ho\u1eb7c 37\u201350 kg<\/td>\n<\/tr>\n
    Tr\u1ebb em 3 \u0111\u1ebfn d\u01b0\u1edbi 6 tu\u1ed5i<\/td>\nKh\u1edfi \u0111\u1ea7u<\/td>\n10\u201315 mg\/kg\/ng\u00e0y, chia 3 l\u1ea7n<\/td>\n<\/td>\n<\/tr>\n
    Sau 3 ng\u00e0y<\/td>\nT\u0103ng \u0111\u1ebfn 25\u201330 mg\/kg\/ng\u00e0y, chia 3 l\u1ea7n<\/td>\n<\/td>\n<\/tr>\n
    \u0110au th\u1ea7n\u00a0\u00a0kinh ngo\u1ea1i bi\u00ean<\/td>\nNg\u00e0y 1<\/td>\n1 vi\u00ean x 1 l\u1ea7n\/ng\u00e0y<\/td>\n<\/td>\n<\/tr>\n
    Ng\u00e0y 2<\/td>\n1 vi\u00ean x 2 l\u1ea7n\/ng\u00e0y<\/td>\n<\/td>\n<\/tr>\n
    Ng\u00e0y 3<\/td>\n1 vi\u00ean x 3 l\u1ea7n\/ng\u00e0y<\/td>\n<\/td>\n<\/tr>\n
    Sau \u0111\u00f3<\/td>\nT\u0103ng 1 vi\u00ean\/ng\u00e0y n\u1ebfu c\u1ea7n, t\u1ed1i \u0111a 6 vi\u00ean\/ng\u00e0y<\/td>\nChia 3 l\u1ea7n\/ng\u00e0y<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

    C\u00e1ch s\u1eed d\u1ee5ng<\/b><\/h3>\n

    Thu\u1ed1c c\u1ea7n \u0111\u01b0\u1ee3c u\u1ed1ng nguy\u00ean vi\u00ean nang c\u00f9ng v\u1edbi n\u01b0\u1edbc, th\u1eddi \u0111i\u1ec3m s\u1eed d\u1ee5ng kh\u00f4ng nh\u1ea5t thi\u1ebft ph\u1ea3i theo b\u1eefa \u0103n.<\/p>\n

    Li\u1ec1u d\u00f9ng n\u00ean \u0111\u01b0\u1ee3c chia \u0111\u1ec1u trong ng\u00e0y, \u0111\u1ea3m b\u1ea3o kho\u1ea3ng c\u00e1ch gi\u1eefa c\u00e1c l\u1ea7n u\u1ed1ng kh\u00f4ng v\u01b0\u1ee3t qu\u00e1 12 gi\u1edd.<\/p>\n

    Khi mu\u1ed1n ng\u01b0ng \u0111i\u1ec1u tr\u1ecb, li\u1ec1u l\u01b0\u1ee3ng ph\u1ea3i \u0111\u01b0\u1ee3c gi\u1ea3m d\u1ea7n trong th\u1eddi gian t\u1ed1i thi\u1ec3u 7 ng\u00e0y, kh\u00f4ng n\u00ean d\u1eebng \u0111\u1ed9t ng\u1ed9t.<\/p>\n

    Tuy\u1ec7t \u0111\u1ed1i kh\u00f4ng t\u1ef1 \u00fd ng\u1eebng d\u00f9ng Galeptic 300 n\u1ebfu ch\u01b0a c\u00f3 s\u1ef1 h\u01b0\u1edbng d\u1eabn t\u1eeb b\u00e1c s\u0129 chuy\u00ean m\u00f4n.<\/p>\n

    Kh\u00f4ng s\u1eed d\u1ee5ng thu\u1ed1c Galeptic 300 trong tr\u01b0\u1eddng h\u1ee3p n\u00e0o?<\/b><\/h2>\n

    Ng\u01b0\u1eddi d\u1ecb \u1ee9ng v\u1edbi Gabapentin v\u00e0 t\u00e1 d\u01b0\u1ee3c c\u00f3 trong Galeptic 300<\/p>\n

    L\u01b0u \u00fd \u0111\u1eb7c bi\u1ec7t khi s\u1eed d\u1ee5ng thu\u1ed1c<\/b><\/h2>\n

    Th\u1eadn tr\u1ecdng<\/b><\/h3>\n

    C\u1ea7n \u0111\u1eb7c bi\u1ec7t l\u01b0u \u00fd khi d\u00f9ng thu\u1ed1c cho ng\u01b0\u1eddi l\u1edbn tu\u1ed5i v\u00e0 nh\u1eefng b\u1ec7nh nh\u00e2n c\u00f3 ch\u1ee9c n\u0103ng th\u1eadn suy gi\u1ea3m.<\/p>\n

    \u0110\u1ed1i v\u1edbi tr\u01b0\u1eddng h\u1ee3p \u0111ang l\u1ecdc m\u00e1u, li\u1ec1u d\u00f9ng c\u1ea7n \u0111\u01b0\u1ee3c hi\u1ec7u ch\u1ec9nh ph\u00f9 h\u1ee3p v\u1edbi t\u00ecnh tr\u1ea1ng l\u1ecdc th\u1eadn.<\/p>\n

    Vi\u1ec7c d\u1eebng thu\u1ed1c \u0111\u1ed9t ng\u1ed9t c\u00f3 th\u1ec3 l\u00e0m t\u0103ng nguy c\u01a1 t\u00e1i xu\u1ea5t hi\u1ec7n c\u00e1c c\u01a1n co gi\u1eadt, do \u0111\u00f3 c\u1ea7n gi\u1ea3m li\u1ec1u d\u1ea7n theo ch\u1ec9 \u0111\u1ecbnh c\u1ee7a b\u00e1c s\u0129.<\/p>\n

    Trong qu\u00e1 tr\u00ecnh s\u1eed d\u1ee5ng, n\u1ebfu xu\u1ea5t hi\u1ec7n c\u00e1c bi\u1ec3u hi\u1ec7n b\u1ea5t th\u01b0\u1eddng tr\u00ean da, c\u1ea7n theo d\u00f5i s\u00e1t sao v\u00ec c\u00f3 th\u1ec3 li\u00ean quan \u0111\u1ebfn h\u1ed9i ch\u1ee9ng Stevens-Johnson \u2013 m\u1ed9t ph\u1ea3n \u1ee9ng da nghi\u00eam tr\u1ecdng.<\/p>\n

    T\u00e1c d\u1ee5ng ph\u1ee5<\/b><\/h3>\n

    Th\u01b0\u1eddng g\u1eb7p<\/h4>\n

    Ng\u01b0\u1eddi d\u00f9ng c\u00f3 th\u1ec3 g\u1eb7p c\u00e1c tri\u1ec7u ch\u1ee9ng nh\u01b0 bu\u1ed3n ng\u1ee7, m\u1ec7t m\u1ecfi ho\u1eb7c ch\u00f3ng m\u1eb7t. M\u1ed9t s\u1ed1 tr\u01b0\u1eddng h\u1ee3p xu\u1ea5t hi\u1ec7n ph\u00f9 n\u1ec1, \u0111au c\u01a1 ho\u1eb7c suy gi\u1ea3m tr\u00ed nh\u1edb. H\u1ec7 ti\u00eau h\u00f3a c\u00f3 th\u1ec3 b\u1ecb \u1ea3nh h\u01b0\u1edfng v\u1edbi bi\u1ec3u hi\u1ec7n nh\u01b0 t\u00e1o b\u00f3n ho\u1eb7c ti\u00eau ch\u1ea3y.<\/p>\n

    \u1ede tr\u1ebb nh\u1ecf, thu\u1ed1c c\u00f3 th\u1ec3 g\u00e2y thay \u0111\u1ed5i h\u00e0nh vi nh\u01b0 d\u1ec5 c\u00e1u g\u1eaft, k\u00edch \u0111\u1ed9ng ho\u1eb7c b\u1ea5t th\u01b0\u1eddng trong c\u1ea3m x\u00fac.<\/p>\n

    \u00cdt g\u1eb7p – hi\u1ebfm g\u1eb7p<\/h4>\n

    C\u00f3 th\u1ec3 xu\u1ea5t hi\u1ec7n c\u00e1c v\u1ea5n \u0111\u1ec1 t\u00e2m l\u00fd nh\u01b0 tr\u1ea7m c\u1ea3m, thay \u0111\u1ed5i c\u1ea3m x\u00fac, gi\u1ea3m ho\u1eb7c m\u1ea5t tr\u00ed nh\u1edb. M\u1ed9t s\u1ed1 ng\u01b0\u1eddi c\u00f3 th\u1ec3 b\u1ecb t\u1ee5t huy\u1ebft \u00e1p, \u0111au t\u1ee9c ng\u1ef1c, ho\u1eb7c c\u00e1c tri\u1ec7u ch\u1ee9ng v\u1ec1 h\u00f4 h\u1ea5p nh\u01b0 vi\u00eam h\u1ecdng, ngh\u1eb9t m\u0169i, ho.<\/p>\n

    Bi\u1ec3u hi\u1ec7n ngo\u00e0i da bao g\u1ed3m ph\u00e1t ban, n\u1ed5i m\u1ea9n, ng\u1ee9a.<\/p>\n

    C\u00e1c t\u00e1c d\u1ee5ng ph\u1ee5 nghi\u00eam tr\u1ecdng h\u01a1n nh\u01b0ng hi\u1ebfm x\u1ea3y ra g\u1ed3m: t\u0103ng c\u00e2n, ph\u00f9 ph\u1ed5i, r\u1ed1i lo\u1ea1n t\u00e2m th\u1ea7n v\u00e0 \u0111\u1eb7c bi\u1ec7t l\u00e0 h\u1ed9i ch\u1ee9ng Stevens-Johnson \u2013 ph\u1ea3n \u1ee9ng d\u1ecb \u1ee9ng da nghi\u00eam tr\u1ecdng c\u1ea7n \u0111\u01b0\u1ee3c x\u1eed l\u00fd y t\u1ebf ngay.<\/p>\n

    T\u01b0\u01a1ng t\u00e1c<\/b><\/h3>\n

    Gabapentin khi s\u1eed d\u1ee5ng c\u00f9ng v\u1edbi c\u00e1c thu\u1ed1c \u0111i\u1ec1u tr\u1ecb \u0111\u1ed9ng kinh ph\u1ed5 bi\u1ebfn nh\u01b0 carbamazepin, phenytoin, acid valproic, phenobarbital hay diazepam kh\u00f4ng l\u00e0m thay \u0111\u1ed5i c\u00e1ch c\u00e1c thu\u1ed1c n\u00e0y \u0111\u01b0\u1ee3c chuy\u1ec3n h\u00f3a trong c\u01a1 th\u1ec3.<\/p>\n

    Tuy nhi\u00ean, n\u1ebfu d\u00f9ng chung v\u1edbi thu\u1ed1c kh\u00e1ng acid, kh\u1ea3 n\u0103ng h\u1ea5p thu c\u1ee7a Gabapentin c\u00f3 th\u1ec3 b\u1ecb gi\u1ea3m kho\u1ea3ng 20%. Do \u0111\u00f3, n\u00ean u\u1ed1ng Gabapentin c\u00e1ch thu\u1ed1c kh\u00e1ng acid \u00edt nh\u1ea5t 2 gi\u1edd \u0111\u1ec3 tr\u00e1nh \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn hi\u1ec7u qu\u1ea3 \u0111i\u1ec1u tr\u1ecb.<\/p>\n

    L\u01b0u \u00fd cho ph\u1ee5 n\u1eef c\u00f3 thai v\u00e0 cho con b\u00fa<\/b><\/h3>\n

    Ch\u1ec9 n\u00ean s\u1eed d\u1ee5ng thu\u1ed1c Galeptic 300 khi th\u1eadt s\u1ef1 c\u1ea7n thi\u1ebft v\u00e0 c\u00f3 ch\u1ec9 \u0111\u1ecbnh r\u00f5 r\u00e0ng t\u1eeb b\u00e1c s\u0129 chuy\u00ean khoa.<\/p>\n

    Gabapentin c\u00f3 kh\u1ea3 n\u0103ng \u0111i v\u00e0o s\u1eefa m\u1eb9, do \u0111\u00f3 c\u1ea7n \u0111\u00e1nh gi\u00e1 k\u1ef9 l\u01b0\u1ee1ng gi\u1eefa l\u1ee3i \u00edch \u0111i\u1ec1u tr\u1ecb v\u00e0 nguy c\u01a1 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn tr\u1ebb b\u00fa m\u1eb9 tr\u01b0\u1edbc khi quy\u1ebft \u0111\u1ecbnh d\u00f9ng thu\u1ed1c.<\/p>\n

    L\u01b0u \u00fd khi s\u1eed d\u1ee5ng cho ng\u01b0\u1eddi l\u00e1i xe v\u00e0 v\u1eadn h\u00e0nh m\u00e1y m\u00f3c<\/b><\/h3>\n

    Thu\u1ed1c c\u00f3 th\u1ec3 g\u00e2y ra m\u1ed9t s\u1ed1 t\u00e1c d\u1ee5ng nh\u01b0 bu\u1ed3n ng\u1ee7, ch\u00f3ng m\u1eb7t, r\u1ed1i lo\u1ea1n th\u1ecb gi\u00e1c. V\u00ec v\u1eady, ng\u01b0\u1eddi \u0111ang \u0111i\u1ec1u tr\u1ecb n\u00ean th\u1eadn tr\u1ecdng khi l\u00e1i xe, v\u1eadn h\u00e0nh m\u00e1y m\u00f3c ho\u1eb7c l\u00e0m c\u00e1c c\u00f4ng vi\u1ec7c c\u1ea7n s\u1ef1 t\u1eadp trung cao<\/p>\n

    Qu\u00e1 li\u1ec1u v\u00e0 x\u1eed tr\u00ed<\/b><\/h3>\n

    Bi\u1ec3u hi\u1ec7n khi d\u00f9ng qu\u00e1 li\u1ec1u: C\u00f3 th\u1ec3 g\u1eb7p c\u00e1c tri\u1ec7u ch\u1ee9ng nh\u01b0 n\u00f3i kh\u00f4ng r\u00f5, l\u01a1 m\u01a1, ti\u00eau ch\u1ea3y, m\u1ea5t t\u1ec9nh t\u00e1o ho\u1eb7c r\u01a1i v\u00e0o tr\u1ea1ng th\u00e1i h\u00f4n m\u00ea.<\/p>\n

    C\u00e1ch x\u1eed l\u00fd: \u0110i\u1ec1u tr\u1ecb ch\u1ee7 y\u1ebfu d\u1ef1a tr\u00ean c\u00e1c tri\u1ec7u ch\u1ee9ng l\u00e2m s\u00e0ng. Trong tr\u01b0\u1eddng h\u1ee3p c\u1ea7n thi\u1ebft, l\u1ecdc m\u00e1u c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c s\u1eed d\u1ee5ng \u0111\u1ec3 h\u1ed7 tr\u1ee3 lo\u1ea1i b\u1ecf thu\u1ed1c ra kh\u1ecfi h\u1ec7 tu\u1ea7n ho\u00e0n.<\/p>\n

    B\u1ea3o qu\u1ea3n<\/b><\/h3>\n

    Gi\u1eef Galeptic 300 \u1edf n\u01a1i kh\u00f4 r\u00e1o, tho\u00e1ng m\u00e1t (<30\u2103), tr\u00e1nh \u00e1nh n\u1eafng qu\u00e1 m\u1ea1nh t\u1eeb m\u1eb7t tr\u1eddi<\/p>\n

    Kh\u00f4ng \u0111\u1ec3 Galeptic 300 trong t\u1ea7m v\u1edbi tr\u1ebb em<\/p>\n

    Kh\u00f4ng s\u1eed d\u1ee5ng Galeptic 300 khi qu\u00e1 h\u1ea1n cho ph\u00e9p<\/p>\n

    S\u1ea3n ph\u1ea9m t\u01b0\u01a1ng t\u1ef1<\/b><\/h2>\n

    Qu\u00fd kh\u00e1ch c\u00f3 th\u1ec3 tham kh\u1ea3o c\u00e1c s\u1ea3n ph\u1ea9m kh\u00e1c c\u1ee7a nh\u00e0 thu\u1ed1c c\u00f3 c\u00f9ng ho\u1ea1t ch\u1ea5t v\u00e0 t\u00e1c d\u1ee5ng v\u1edbi Galeptic 300 nh\u01b0:<\/p>\n

    Savi Gabapentin 300<\/a> c\u00f3 th\u00e0nh ph\u1ea7n ch\u00ednh l\u00e0 Gabapentin 300mg, \u0111\u01b0\u1ee3c s\u1ea3n xu\u1ea5t b\u1edfi C\u00f4ng ty c\u1ed5 ph\u1ea7n D\u01b0\u1ee3c ph\u1ea9m SaVi \u2013 Savipharm, \u0111i\u1ec1u tr\u1ecb c\u00e1c c\u01a1n \u0111\u1ed9ng kinh c\u1ee5c b\u1ed9<\/p>\n

    Neupencap 300mg<\/a> c\u00f3 th\u00e0nh ph\u1ea7n ch\u00ednh l\u00e0 Gabapentin 300mg, \u0111\u01b0\u1ee3c s\u1ea3n xu\u1ea5t b\u1edfi C\u00f4ng ty c\u1ed5 ph\u1ea7n d\u01b0\u1ee3c Danapha, \u0111i\u1ec1u tr\u1ecb c\u00e1c c\u01a1n \u0111\u1ed9ng kinh c\u1ee5c b\u1ed9<\/p>\n

    T\u00e0i li\u1ec7u tham kh\u1ea3o<\/b><\/h2>\n
      \n
    1. T\u1edd H\u01b0\u1edbng d\u1eabn s\u1eed d\u1ee5ng thu\u1ed1c Galeptic 300 \u0111\u01b0\u1ee3c B\u1ed9 Y t\u1ebf ph\u00ea duy\u1ec7t. Xem v\u00e0 t\u1ea3i v\u1ec1 b\u1ea3n PDF \u0111\u1ea7y \u0111\u1ee7 t\u1ea1i \u0111\u00e2y<\/a>. Truy c\u1eadp ng\u00e0y 22 th\u00e1ng 10 n\u0103m 2025<\/li>\n
    2. Chincholkar M (2022). Gabapentinoids: pharmacokinetics, pharmacodynamics and considerations for clinical practice. Br J Pain. Truy c\u1eadp ng\u00e0y 22 th\u00e1ng 10 n\u0103m 2025 t\u1eeb: https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC7265598\/<\/a><\/li>\n<\/ol>\n","protected":false},"excerpt":{"rendered":"

      Thu\u1ed1c Galeptic 300 c\u00f3 ho\u1ea1t ch\u1ea5t ch\u00ednh l\u00e0 Gabapentin, \u0111\u01b0\u1ee3c d\u00f9ng trong ki\u1ec3m so\u00e1t c\u01a1n \u0111\u1ed9ng kinh c\u1ee5c b\u1ed9 v\u00e0 h\u1ed7 tr\u1ee3 \u0111i\u1ec1u tr\u1ecb ch\u1ee9ng \u0111au do t\u1ed5n th\u01b0\u01a1ng d\u00e2y th\u1ea7n kinh ngo\u1ea1i vi.<\/p>\n","protected":false},"author":1,"featured_media":145798,"comment_status":"open","ping_status":"closed","template":"","meta":{"_acf_changed":false},"product_cat":[89],"product_tag":[],"class_list":{"0":"post-145792","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-thuoc","8":"first","9":"instock","10":"shipping-taxable","11":"purchasable","12":"product-type-simple"},"acf":[],"_links":{"self":[{"href":"https:\/\/vnras.com\/drug\/wp-json\/wp\/v2\/product\/145792","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/vnras.com\/drug\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/vnras.com\/drug\/wp-json\/wp\/v2\/types\/product"}],"author":[{"embeddable":true,"href":"https:\/\/vnras.com\/drug\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/vnras.com\/drug\/wp-json\/wp\/v2\/comments?post=145792"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/vnras.com\/drug\/wp-json\/wp\/v2\/media\/145798"}],"wp:attachment":[{"href":"https:\/\/vnras.com\/drug\/wp-json\/wp\/v2\/media?parent=145792"}],"wp:term":[{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/vnras.com\/drug\/wp-json\/wp\/v2\/product_cat?post=145792"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/vnras.com\/drug\/wp-json\/wp\/v2\/product_tag?post=145792"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}